• +39 0964 913405
  • info@head-sa.com

BERGACYN®

BERGACYN®

THE SHAPE OF THINGS TO COME

People are suffering from Metabolic Syndrome & Obesity worldwide


People experienced concomitant Fatty Liver Disease


of patients with Metabolic Syndrome and Fatty Liver undergo Heart Failure and Cancer

BERGACYN® is an innovative and unique combination of Bergamot Polyphenolic Fraction (BPF) plus Cynara Cardunculus extract.

It represents the best natural and safer non pharmacological intervention for counteracting Metabolic Disorders (diabetes, hypertension, high “bad” cholesterol and triglycerides) FaMy Liver andCancer.


BERGACYN® REDUCES


by 38%, 45% and 28%
serum cholesterol,
tryglycerides
and glucose,
respectively


inflammation of vascular and non vascular tissues

oxidative stress and improves vascular function
via enhanced nitric oxide release
by 40% liver Iibrosis and dysfunction in patients
anticancer drug-induced Heart Failure


BERGACYN® ENHANCES

proliferation of cardiac stem cells


BERGACYN® INHIBITS

proliferation
of cardiac stem cells

NORMAL – STEATOSIS
BERGACYN 5 – BERGACYN 20


fat accumulation (steatosis) in liver tissues
proliferation of human hepatocarcinoma cell line


BERGACYN® PRODUCES

anti-cancer effect in patients via inhibition of STAT-3 pathway

• PAGE AVAILABLE IN English